{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:10:02Z","timestamp":1759165802812,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jconrel.2022.07.043","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T19:20:34Z","timestamp":1660159234000},"page":"983-991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Artificial primary-miRNAs as a platform for simultaneous delivery of siRNA and antisense oligonucleotide for multimodal gene regulation"],"prefix":"10.1016","volume":"349","author":[{"given":"Hyunsook","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Chul","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyukjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jconrel.2022.07.043_bb0005","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nchem.2852","article-title":"Engineering nucleic acid structures for programmable molecular circuitry and intracellular biocomputation","volume":"9","author":"Li","year":"2017","journal-title":"Nat. Chem."},{"issue":"22","key":"10.1016\/j.jconrel.2022.07.043_bb0010","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1039\/D1SC00587A","article-title":"DNA nanostructure-based nucleic acid probes: construction and biological applications","volume":"12","author":"Wang","year":"2021","journal-title":"Chem. Sci."},{"issue":"12","key":"10.1016\/j.jconrel.2022.07.043_bb0015","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.tibtech.2021.03.007","article-title":"Smart nucleic acids as future therapeutics","volume":"39","author":"Zhang","year":"2021","journal-title":"Trends Biotechnol."},{"issue":"22","key":"10.1016\/j.jconrel.2022.07.043_bb0020","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.1021\/acs.chemrev.0c01332","article-title":"Self-assembling nucleic acid nanostructures functionalized with aptamers","volume":"121","author":"Krissanaprasit","year":"2021","journal-title":"Chem. Rev."},{"issue":"19","key":"10.1016\/j.jconrel.2022.07.043_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001046","article-title":"Gene therapy based on nucleic acid nanostructure","volume":"9","author":"Wu","year":"2020","journal-title":"Adv Healthc Mater"},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.043_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic siRNAs in adult mice","volume":"327","author":"Sorensen","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"17","key":"10.1016\/j.jconrel.2022.07.043_bb0035","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.171251798","article-title":"Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems","volume":"98","author":"Caplen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.jconrel.2022.07.043_bb0040","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1021\/acs.nanolett.8b01267","article-title":"Enzymatic synthesis of self-assembled dicer substrate RNA nanostructures for programmable gene silencing","volume":"18","author":"Jang","year":"2018","journal-title":"Nano Lett."},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.043_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1594","article-title":"The powerful world of antisense oligonucleotides: from bench to bedside","volume":"11","author":"Quemener","year":"2020","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.043_bb0050","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/anie.202011174","article-title":"Branched antisense and siRNA co-assembled Nanoplatform for combined gene silencing and tumor therapy","volume":"60","author":"Liu","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"10.1016\/j.jconrel.2022.07.043_bb0055","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.ymthe.2019.04.018","article-title":"Delivery of anti-miRNA for triple-negative breast Cancer therapy using RNA nanoparticles targeting stem cell marker CD133","volume":"27","author":"Yin","year":"2019","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.043_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6956","key":"10.1016\/j.jconrel.2022.07.043_bb0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.jconrel.2022.07.043_bb0070","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1093\/nar\/gkq181","article-title":"Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing","volume":"38","author":"Deleavey","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"10.1016\/j.jconrel.2022.07.043_bb0075","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1021\/acs.jmedchem.6b00551","article-title":"The medicinal chemistry of therapeutic oligonucleotides","volume":"59","author":"Wan","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.043_bb0080","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1038\/s41598-017-03850-2","article-title":"LNA\/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts","volume":"7","author":"Touznik","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.043_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/cgt.2016.25","article-title":"Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach","volume":"23","author":"Nedaeinia","year":"2016","journal-title":"Cancer Gene Ther."},{"issue":"13","key":"10.1016\/j.jconrel.2022.07.043_bb0090","doi-asserted-by":"crossref","first-page":"E1881","DOI":"10.1073\/pnas.1602532113","article-title":"Re-evaluation of the roles of DROSHA, export in 5, and DICER in microRNA biogenesis","volume":"113","author":"Kim","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.043_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf4398","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"issue":"51","key":"10.1016\/j.jconrel.2022.07.043_bb0100","doi-asserted-by":"crossref","first-page":"20687","DOI":"10.1073\/pnas.1311639110","article-title":"Lower and upper stem-single-stranded RNA junctions together determine the Drosha cleavage site","volume":"110","author":"Ma","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.043_bb0105","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.01.031","article-title":"Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing","volume":"152","author":"Auyeung","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.043_bb0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.molcel.2018.11.005","article-title":"Molecular basis for the single-nucleotide precision of primary microRNA processing","volume":"73","author":"Kwon","year":"2019","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.043_bb0115","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41598-018-36620-9","article-title":"A systematic study on the influence of thermodynamic asymmetry of 5\u2032-ends of siRNA duplexes in relation to their silencing potency","volume":"9","author":"Lisowiec-Wachnicka","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.043_bb0120","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.02.049","article-title":"Chemical modification of siRNAs to improve serum stability without loss of efficacy","volume":"342","author":"Choung","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.043_bb0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1261\/rna.031120.111","article-title":"Comprehensive evaluation of canonical versus dicer-substrate siRNA in vitro and in vivo","volume":"18","author":"Foster","year":"2012","journal-title":"RNA"},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.043_bb0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nn.4508","article-title":"Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy","volume":"20","author":"Corey","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2022.07.043_bb0135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12935-020-01394-6","article-title":"Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies","volume":"20","author":"Javanmard","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.jconrel.2022.07.043_bb0140","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/neuonc\/nor033","article-title":"Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo","volume":"13","author":"Gaur","year":"2011","journal-title":"Neuro-Oncology"},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.043_bb0145","first-page":"1660","article-title":"miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma","volume":"27","author":"Zhu","year":"2012","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.jconrel.2022.07.043_bb0150","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/labinvest.2015.105","article-title":"miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma","volume":"95","author":"Jiang","year":"2015","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2022.07.043_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12935-015-0228-7","article-title":"Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells","volume":"15","author":"Tao","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.043_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135919","article-title":"Assessment of artificial MiRNA architectures for higher knockdown efficiencies without the undesired effects in mice","volume":"10","author":"Miura","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.043_bb0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/mt.2014.205","article-title":"Multiplexing seven miRNA-based shRNAs to suppress HIV replication","volume":"23","author":"Choi","year":"2015","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.043_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.2008.0123","article-title":"Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs","volume":"18","author":"Collingwood","year":"2008","journal-title":"Oligonucleotides"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922004795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922004795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:37:12Z","timestamp":1759163832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922004795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"alternative-id":["S0168365922004795"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"type":"print","value":"0168-3659"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial primary-miRNAs as a platform for simultaneous delivery of siRNA and antisense oligonucleotide for multimodal gene regulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}